Vermont H0533 mandates congenital cytomegalovirus screening in newborns and establishes an advisory committee.

Vermont H0533 requires the Department of Health to include congenital cytomegalovirus in its newborn screening program. It also creates the Congenital Cytomegalovirus Advisory Committee to advise on screening validity, costs, and standards for follow-up care and public education. The committee comprises healthcare professionals, parents, and educators, and it submits annual reports to legislative committees. The act takes effect on July 1, 2026.

Vermont H0533 mandates congenital cytomegalovirus screening in newborns and establishes an advisory committee.

Vermont H0533 requires the Department of Health to include congenital cytomegalovirus in its newborn screening program. It also creates the Congenital Cytomegalovirus Advisory Committee to advise on screening validity, costs, and standards for follow-up care and public education. The committee comprises healthcare professionals, parents, and educators, and it submits annual reports to legislative committees. The act takes effect on July 1, 2026.